Tải bản đầy đủ (.pdf) (3 trang)

Andersons pediatric cardiology 1675

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.23 KB, 3 trang )

193.YangCF,YangCC,LiaoHC,etal.Veryearly
treatmentforInfantile-onsetpompedisease
contributestobetteroutcomes.JPediatr.
2016;169:174–180e171.
194.MaronBJ,GottdienerJS,BonowRO,Epstein
SE.Hypertrophiccardiomyopathywithunusual
locationsofleftventricularhypertrophy
undetectablebyM-modeechocardiography.
Identificationbywide-angletwo-dimensional
echocardiography.Circulation.1981;63(2):409–
418.
195.MaronBJ,BonowRO,SeshagiriTN,Roberts
WC,EpsteinSE.Hypertrophiccardiomyopathy
withventricularseptalhypertrophylocalizedto
theapicalregionoftheleftventricle(apical
hypertrophiccardiomyopathy).AmJCardiol.
1982;49(8):1838–1848.
196.YamaguchiH,IshimuraT,NishiyamaS,etal.
Hypertrophicnonobstructivecardiomyopathy
withgiantnegativeTwaves(apical
hypertrophy):ventriculographicand
echocardiographicfeaturesin30patients.AmJ
Cardiol.1979;44(3):401–412.
197.ShapiroLM,McKennaWJ.Distributionofleft
ventricularhypertrophyinhypertrophic
cardiomyopathy:atwo-dimensional
echocardiographicstudy.JAmCollCardiol.


1983;2(3):437–444.
198.MaronMS,HauserTH,DubrowE,etal.Right


ventricularinvolvementinhypertrophic
cardiomyopathy.AmJCardiol.
2007;100(8):1293–1298.
199.KwonDH,SetserRM,ThamilarasanM,etal.
Abnormalpapillarymusclemorphologyis
independentlyassociatedwithincreasedleft
ventricularoutflowtractobstructionin
hypertrophiccardiomyopathy.Heart.
2008;94(10):1295–1301.
200.MinakataK,DearaniJA,NishimuraRA,Maron
BJ,DanielsonGK.Extendedseptalmyectomy
forhypertrophicobstructivecardiomyopathy
withanomalousmitralpapillarymusclesor
chordae.JThoracCardiovascSurg.
2004;127(2):481–489.
201.HarriganCJ,AppelbaumE,MaronBJ,etal.
Significanceofpapillarymuscleabnormalities
identifiedbycardiovascularmagneticresonance
inhypertrophiccardiomyopathy.AmJCardiol.
2008;101(5):668–673.
202.KluesHG,RobertsWC,MaronBJ.Anomalous
insertionofpapillarymuscledirectlyinto
anteriormitralleafletinhypertrophic
cardiomyopathy.Significanceinproducingleft
ventricularoutflowobstruction.Circulation.


1991;84(3):1188–1197.
203.SchantzD,BensonL,WindramJ,etal.
Abnormalmitralvalvedimensionsinpediatric

patientswithhypertrophiccardiomyopathy.
PediatrCardiol.2016;37(4):784–788.
204.SorajjaP,OmmenSR,NishimuraRA,etal.
Myocardialbridginginadultpatientswith
hypertrophiccardiomyopathy.JAmColl
Cardiol.2003;42(5):889–894.
205.YetmanAT,McCrindleBW,MacDonaldC,
FreedomRM,GowR.Myocardialbridgingin
childrenwithhypertrophiccardiomyopathy–a
riskfactorforsuddendeath.NEnglJMed.
1998;339(17):1201–1209.
206.MohiddinSA,BegleyD,ShihJ,FananapazirL.
Myocardialbridgingdoesnotpredictsudden
deathinchildrenwithhypertrophic
cardiomyopathybutisassociatedwithmore
severecardiacdisease.JAmCollCardiol.
2000;36(7):2270–2278.
207.BassoC,ThieneG,Mackey-BojackS,etal.
Myocardialbridging,afrequentcomponentof
thehypertrophiccardiomyopathyphenotype,
lackssystematicassociationwithsuddencardiac
death.EurHeartJ.2009;30(13):1627–1634.
208.KunkalaMR,SchaffHV,BurkhartH,etal.
Outcomeofrepairofmyocardialbridgingatthe



×